JPH0739413B2 - Method for producing benzylphthalazinone derivative - Google Patents
Method for producing benzylphthalazinone derivativeInfo
- Publication number
- JPH0739413B2 JPH0739413B2 JP33284491A JP33284491A JPH0739413B2 JP H0739413 B2 JPH0739413 B2 JP H0739413B2 JP 33284491 A JP33284491 A JP 33284491A JP 33284491 A JP33284491 A JP 33284491A JP H0739413 B2 JPH0739413 B2 JP H0739413B2
- Authority
- JP
- Japan
- Prior art keywords
- salt
- general formula
- derivative
- producing
- benzylphthalazinone
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 238000004519 manufacturing process Methods 0.000 title claims description 11
- JUCCMEHWBGPJKS-UHFFFAOYSA-N 4-benzyl-2h-phthalazin-1-one Chemical class C12=CC=CC=C2C(=O)NN=C1CC1=CC=CC=C1 JUCCMEHWBGPJKS-UHFFFAOYSA-N 0.000 title claims description 9
- 150000003839 salts Chemical class 0.000 claims description 21
- 150000001875 compounds Chemical class 0.000 claims description 17
- RIOQSEWOXXDEQQ-UHFFFAOYSA-N triphenylphosphine Chemical compound C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1 RIOQSEWOXXDEQQ-UHFFFAOYSA-N 0.000 claims description 16
- 238000006243 chemical reaction Methods 0.000 claims description 14
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical group Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims description 12
- 125000000217 alkyl group Chemical group 0.000 claims description 9
- 239000003795 chemical substances by application Substances 0.000 claims description 6
- 238000000034 method Methods 0.000 claims description 6
- FAMRKDQNMBBFBR-BQYQJAHWSA-N diethyl azodicarboxylate Substances CCOC(=O)\N=N\C(=O)OCC FAMRKDQNMBBFBR-BQYQJAHWSA-N 0.000 claims description 5
- FAMRKDQNMBBFBR-UHFFFAOYSA-N ethyl n-ethoxycarbonyliminocarbamate Chemical compound CCOC(=O)N=NC(=O)OCC FAMRKDQNMBBFBR-UHFFFAOYSA-N 0.000 claims description 5
- -1 azodicarboxylic acid ester Chemical class 0.000 claims description 4
- 230000018044 dehydration Effects 0.000 claims description 4
- 238000006297 dehydration reaction Methods 0.000 claims description 4
- 125000005843 halogen group Chemical group 0.000 claims description 4
- 125000003118 aryl group Chemical group 0.000 claims description 3
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 3
- 150000003003 phosphines Chemical class 0.000 claims description 3
- VVWRJUBEIPHGQF-UHFFFAOYSA-N propan-2-yl n-propan-2-yloxycarbonyliminocarbamate Chemical compound CC(C)OC(=O)N=NC(=O)OC(C)C VVWRJUBEIPHGQF-UHFFFAOYSA-N 0.000 claims description 3
- 229910052801 chlorine Inorganic materials 0.000 claims description 2
- 125000001309 chloro group Chemical group Cl* 0.000 claims description 2
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 claims 1
- 238000009833 condensation Methods 0.000 claims 1
- IJAPPYDYQCXOEF-UHFFFAOYSA-N phthalazin-1(2H)-one Chemical class C1=CC=C2C(=O)NN=CC2=C1 IJAPPYDYQCXOEF-UHFFFAOYSA-N 0.000 claims 1
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 18
- 239000000126 substance Substances 0.000 description 12
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 9
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 8
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 8
- 239000000047 product Substances 0.000 description 7
- 239000013078 crystal Substances 0.000 description 6
- 239000002253 acid Substances 0.000 description 5
- GLXOHWLGZMRLRM-UHFFFAOYSA-N 1-methylazepan-4-ol Chemical compound CN1CCCC(O)CC1 GLXOHWLGZMRLRM-UHFFFAOYSA-N 0.000 description 4
- MBUVEWMHONZEQD-UHFFFAOYSA-N Azeptin Chemical compound C1CN(C)CCCC1N1C(=O)C2=CC=CC=C2C(CC=2C=CC(Cl)=CC=2)=N1 MBUVEWMHONZEQD-UHFFFAOYSA-N 0.000 description 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 4
- NLXGCQIEVZYDRS-UHFFFAOYSA-N 4-[(4-chlorophenyl)methyl]-2h-phthalazin-1-one Chemical compound C1=CC(Cl)=CC=C1CC1=NNC(=O)C2=CC=CC=C12 NLXGCQIEVZYDRS-UHFFFAOYSA-N 0.000 description 3
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 3
- 238000002425 crystallisation Methods 0.000 description 3
- 230000000704 physical effect Effects 0.000 description 3
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 2
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 2
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 2
- DKGAVHZHDRPRBM-UHFFFAOYSA-N Tert-Butanol Chemical compound CC(C)(C)O DKGAVHZHDRPRBM-UHFFFAOYSA-N 0.000 description 2
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 2
- 150000007513 acids Chemical class 0.000 description 2
- 239000006227 byproduct Substances 0.000 description 2
- 230000008025 crystallization Effects 0.000 description 2
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 2
- XMBWDFGMSWQBCA-UHFFFAOYSA-N hydrogen iodide Chemical compound I XMBWDFGMSWQBCA-UHFFFAOYSA-N 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- AVQQQNCBBIEMEU-UHFFFAOYSA-N 1,1,3,3-tetramethylurea Chemical compound CN(C)C(=O)N(C)C AVQQQNCBBIEMEU-UHFFFAOYSA-N 0.000 description 1
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 1
- BMYNFMYTOJXKLE-UHFFFAOYSA-N 3-azaniumyl-2-hydroxypropanoate Chemical compound NCC(O)C(O)=O BMYNFMYTOJXKLE-UHFFFAOYSA-N 0.000 description 1
- 125000006283 4-chlorobenzyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1Cl)C([H])([H])* 0.000 description 1
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical group [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-M Bicarbonate Chemical compound OC([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-M 0.000 description 1
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical group [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 1
- ZAFNJMIOTHYJRJ-UHFFFAOYSA-N Diisopropyl ether Chemical compound CC(C)OC(C)C ZAFNJMIOTHYJRJ-UHFFFAOYSA-N 0.000 description 1
- CPELXLSAUQHCOX-UHFFFAOYSA-N Hydrogen bromide Chemical compound Br CPELXLSAUQHCOX-UHFFFAOYSA-N 0.000 description 1
- FXHOOIRPVKKKFG-UHFFFAOYSA-N N,N-Dimethylacetamide Chemical compound CN(C)C(C)=O FXHOOIRPVKKKFG-UHFFFAOYSA-N 0.000 description 1
- SECXISVLQFMRJM-UHFFFAOYSA-N N-Methylpyrrolidone Chemical compound CN1CCCC1=O SECXISVLQFMRJM-UHFFFAOYSA-N 0.000 description 1
- AMQJEAYHLZJPGS-UHFFFAOYSA-N N-Pentanol Chemical compound CCCCCO AMQJEAYHLZJPGS-UHFFFAOYSA-N 0.000 description 1
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 1
- OFOBLEOULBTSOW-UHFFFAOYSA-N Propanedioic acid Natural products OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
- GUGOEEXESWIERI-UHFFFAOYSA-N Terfenadine Chemical compound C1=CC(C(C)(C)C)=CC=C1C(O)CCCN1CCC(C(O)(C=2C=CC=CC=2)C=2C=CC=CC=2)CC1 GUGOEEXESWIERI-UHFFFAOYSA-N 0.000 description 1
- 238000000862 absorption spectrum Methods 0.000 description 1
- 229910052783 alkali metal Inorganic materials 0.000 description 1
- 150000001408 amides Chemical class 0.000 description 1
- 230000001387 anti-histamine Effects 0.000 description 1
- 239000000739 antihistaminic agent Substances 0.000 description 1
- 150000004945 aromatic hydrocarbons Chemical class 0.000 description 1
- SRSXLGNVWSONIS-UHFFFAOYSA-N benzenesulfonic acid Chemical class OS(=O)(=O)C1=CC=CC=C1 SRSXLGNVWSONIS-UHFFFAOYSA-N 0.000 description 1
- 150000007942 carboxylates Chemical class 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 239000007810 chemical reaction solvent Substances 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000000921 elemental analysis Methods 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 150000002170 ethers Chemical class 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- VZCYOOQTPOCHFL-OWOJBTEDSA-L fumarate(2-) Chemical class [O-]C(=O)\C=C\C([O-])=O VZCYOOQTPOCHFL-OWOJBTEDSA-L 0.000 description 1
- 150000002391 heterocyclic compounds Chemical class 0.000 description 1
- GNOIPBMMFNIUFM-UHFFFAOYSA-N hexamethylphosphoric triamide Chemical compound CN(C)P(=O)(N(C)C)N(C)C GNOIPBMMFNIUFM-UHFFFAOYSA-N 0.000 description 1
- 229940071870 hydroiodic acid Drugs 0.000 description 1
- 239000012442 inert solvent Substances 0.000 description 1
- 229910052740 iodine Inorganic materials 0.000 description 1
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 150000003893 lactate salts Chemical class 0.000 description 1
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 1
- 239000011976 maleic acid Substances 0.000 description 1
- 238000001819 mass spectrum Methods 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- AUHZEENZYGFFBQ-UHFFFAOYSA-N mesitylene Substances CC1=CC(C)=CC(C)=C1 AUHZEENZYGFFBQ-UHFFFAOYSA-N 0.000 description 1
- 125000001827 mesitylenyl group Chemical group [H]C1=C(C(*)=C(C([H])=C1C([H])([H])[H])C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- AFVFQIVMOAPDHO-UHFFFAOYSA-M methanesulfonate group Chemical class CS(=O)(=O)[O-] AFVFQIVMOAPDHO-UHFFFAOYSA-M 0.000 description 1
- 150000007522 mineralic acids Chemical class 0.000 description 1
- 125000004108 n-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 1
- XAEFZNCEHLXOMS-UHFFFAOYSA-M potassium benzoate Chemical compound [K+].[O-]C(=O)C1=CC=CC=C1 XAEFZNCEHLXOMS-UHFFFAOYSA-M 0.000 description 1
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 238000000425 proton nuclear magnetic resonance spectrum Methods 0.000 description 1
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 1
- 230000008707 rearrangement Effects 0.000 description 1
- 159000000000 sodium salts Chemical class 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 150000003462 sulfoxides Chemical class 0.000 description 1
- LCAAMXMULMCKLJ-UHFFFAOYSA-N talastine Chemical class C12=CC=CC=C2C(=O)N(CCN(C)C)N=C1CC1=CC=CC=C1 LCAAMXMULMCKLJ-UHFFFAOYSA-N 0.000 description 1
- 229960002742 talastine Drugs 0.000 description 1
- 150000003892 tartrate salts Chemical class 0.000 description 1
- LBLYYCQCTBFVLH-UHFFFAOYSA-M toluenesulfonate group Chemical group C=1(C(=CC=CC1)S(=O)(=O)[O-])C LBLYYCQCTBFVLH-UHFFFAOYSA-M 0.000 description 1
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 1
Landscapes
- Plural Heterocyclic Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Description
【0001】[0001]
【産業上の利用分野】本発明は、医薬として有用なベン
ジルフタラジノン誘導体またはその塩を高収率で得る改
良製法に関するものである。BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to an improved process for producing a benzylphthalazinone derivative or a salt thereof which is useful as a medicine in a high yield.
【0002】さらに詳しくは、本発明は一般式(3)More specifically, the present invention has the general formula (3)
【0003】[0003]
【化6】 [Chemical 6]
【0004】(式中、Xはハロゲン原子を示し、そして
R1 は低級アルキル基を示す)(Wherein X represents a halogen atom and R 1 represents a lower alkyl group)
【0005】で表わされるベンジルフタラジノン誘導体
(いわゆる、ベンジルフタラゾン誘導体)およびその塩
の製法に関するものである。The present invention relates to a method for producing a benzylphthalazinone derivative represented by (so-called benzylphthalazone derivative) and a salt thereof.
【0006】[0006]
【従来の技術】特公昭55−31154号公報におい
て、一般式(3)で表わされる化合物が抗ヒスタミン剤
として有用であること、および同化合物のサイクルアン
モニウム転位を利用した製造方法(実施例10)が開示
されている。この製造方法によると、粗製最終生成物が
90%以上の収率で得られるとされているけれども、そ
の中には多量の副反応物が含まれており、目的物を結晶
化により単離すると収率は30%以下である。2. Description of the Related Art Japanese Patent Publication No. 55-31154 discloses that a compound represented by the general formula (3) is useful as an antihistamine and a production method (Example 10) utilizing the cycle ammonium rearrangement of the compound. Has been done. According to this production method, the crude final product is said to be obtained in a yield of 90% or more, but it contains a large amount of by-products, and the target product is isolated by crystallization. The yield is 30% or less.
【0007】[0007]
【発明が解決しようとする課題】上記のとおり、従来法
は収率が極めて低いため、より高収率な製造方法の確立
が望まれる。As described above, since the conventional method has a very low yield, it is desired to establish a production method with a higher yield.
【0008】[0008]
【課題を解決するための手段】本発明者は、鋭意研究の
結果、高収率な製造方法を確立した。As a result of earnest research, the present inventor has established a high-yield production method.
【0009】すなわち、本発明は一般式(1)That is, the present invention has the general formula (1)
【0010】[0010]
【化7】 [Chemical 7]
【0011】(式中、Xはハロゲン原子を示す)で表わ
される化合物またはその塩を、一般式(2)The compound represented by the formula (wherein X represents a halogen atom) or a salt thereof is represented by the general formula (2):
【0012】[0012]
【化8】 [Chemical 8]
【0013】(式中、R1 は低級アルキル基を示す)で
表わされる化合物またはその塩と、脱水縮合剤の存在下
に反応させることを特徴とする一般式(3)The compound represented by the formula (wherein R 1 represents a lower alkyl group) or a salt thereof is reacted in the presence of a dehydration condensing agent, and the compound is represented by the general formula (3).
【0014】[0014]
【化9】 [Chemical 9]
【0015】(式中、XおよびR1 は前記の定義に同
じ)で表わされるベンジルフタラジノン誘導体およびそ
の塩の製造方法である。A process for producing a benzylphthalazinone derivative represented by the formula (wherein X and R 1 are as defined above) and salts thereof.
【0016】一般式(3)におけるハロゲン原子として
は、塩素原子、臭素原子、沃素原子などがあげられ、ま
たR1 の低級アルキル基としては、メチル基、エチル
基、プロピル基などがあげられる。Examples of the halogen atom in the general formula (3) include chlorine atom, bromine atom and iodine atom, and examples of the lower alkyl group of R 1 include methyl group, ethyl group and propyl group.
【0017】一般式(3)の化合物の塩としては、塩酸
塩、硫酸塩、炭酸塩、重炭酸塩、臭化水素酸塩、沃化水
素酸塩などの無機酸塩、酢酸塩、マレイン酸塩、フマー
ル酸塩、乳酸塩、酒石酸塩などの有機カルボン酸塩、メ
タンスルホン酸塩、ベンゼンスルホン酸塩、トルエンス
ルホン酸塩などの有機スルホン酸塩等の酸付加塩があげ
られる。Examples of the salt of the compound represented by the general formula (3) include inorganic acid salts such as hydrochloride, sulfate, carbonate, bicarbonate, hydrobromide and hydroiodide, acetate and maleic acid. Examples thereof include salts, organic carboxylates such as fumarates, lactates and tartrates, and acid addition salts such as methanesulfonates, benzenesulfonates and toluenesulfonates.
【0018】一般式(1)の化合物の塩としては、上記
一般式(3)の化合物の塩と同様の塩があげられる。ま
た一般式(2)の化合物の塩としては、上記一般式
(3)の化合物における酸付加塩のほかに、ナトリウム
塩、カリウム塩などのアルカリ金属塩があげられる。Examples of the salt of the compound of the general formula (1) include the same salts as the salt of the compound of the general formula (3). In addition to the acid addition salt in the compound of the general formula (3), the salt of the compound of the general formula (2) includes alkali metal salts such as sodium salt and potassium salt.
【0019】脱水縮合剤としては、好ましいものとして
例えば、アゾカルボン酸エステルとホスフィン誘導体と
の組み合わせを用いることができる。具体的には、一般
式(4)As the dehydrating condensing agent, for example, a combination of an azocarboxylic acid ester and a phosphine derivative can be preferably used. Specifically, the general formula (4)
【0020】[0020]
【化10】 [Chemical 10]
【0021】(式中、R2 は低級アルキル基を示す)で
表わされるアゾジカルボン酸エステルと、一般式(5)An azodicarboxylic acid ester represented by the formula (wherein R 2 represents a lower alkyl group);
【0022】[0022]
【化11】 (R3)3P (5)Embedded image (R 3 ) 3 P (5)
【0023】(式中、R3はアリール基または低級アル
キル基を示す)で表わされるホスフィン誘導体とを用い
ることができる。A phosphine derivative represented by the formula (wherein R 3 represents an aryl group or a lower alkyl group) can be used.
【0024】R2の低級アルキル基としては、メチル
基、エチル基、イソプロピル基などがあげられる。R3
のアリール基としてはフェニル基などが、またR3の低
級アルキル基としてはn−ブチル基などがあげられる。
最も好ましい脱水縮合剤としては、ジエチルアゾジカル
ボキシレートとトリフェニルホスフィンとを組合わせた
もの、あるいはジイソプロピルアゾジカルボキシレート
とトリフェニルホスフィンとを組合わせたものがあげら
れる。Examples of the lower alkyl group for R 2 include a methyl group, an ethyl group and an isopropyl group. R 3
Examples of the aryl group include a phenyl group, and examples of the lower alkyl group of R 3 include an n-butyl group.
The most preferable dehydration condensing agent is a combination of diethyl azodicarboxylate and triphenylphosphine, or a combination of diisopropyl azodicarboxylate and triphenylphosphine.
【0025】本発明を実施する場合の手順などは、広範
囲に亘って変更することができる。The procedure for carrying out the present invention can be changed over a wide range.
【0026】本発明の反応において使用する原料の量
は、厳密に臨界的なものではない。一般式(1)で表わ
される化合物対一般式(2)によって表わされる化合物
のモル比は、例えば、約1:1またはそれ以下ないし約
0.5:1またはそれ以上に亘ることができる。好まし
くは、約1:1ないし約0.8:1の範囲を、本発明の
範囲を逸脱することなく使用することができる。The amount of raw material used in the reaction of the present invention is not strictly critical. The molar ratio of the compound represented by general formula (1) to the compound represented by general formula (2) can range, for example, from about 1: 1 or less to about 0.5: 1 or more. Preferably, a range of about 1: 1 to about 0.8: 1 can be used without departing from the scope of the invention.
【0027】本発明の反応を実施する場合の反応温度
は、厳密に臨界的なものではなく、約−80℃〜約10
0℃で行うことができる。副生成物の生成を抑制するた
めに、−20℃またはそれ以下の温度で反応を行うこと
が望ましい。The reaction temperature when carrying out the reaction of the present invention is not strictly critical and is from about -80 ° C to about 10 ° C.
It can be carried out at 0 ° C. In order to suppress the production of by-products, it is desirable to carry out the reaction at a temperature of -20 ° C or lower.
【0028】本発明の反応は、大気圧下で実施すること
が出来る。尤も、反応を効果的に遂行するためにその他
の反応条件、使用成分、反応速度などに応じて、一層高
い圧力または一層低い圧力を使用することも出来る。The reaction of the present invention can be carried out under atmospheric pressure. However, higher or lower pressure may be used depending on other reaction conditions, components used, reaction rate, etc. in order to effectively carry out the reaction.
【0029】本発明の反応は不活性溶媒中で実施するこ
とができる。The reaction of the present invention can be carried out in an inert solvent.
【0030】反応溶媒としては、反応を阻害しないもの
であればよく、反応原料が完全に溶解しないものであっ
てもよい。例えば、ベンゾール、メシチレン、トルオー
ル、キシロールなどの芳香族炭化水素;ピリジンなどの
複素環式化合物;ジエチルエーテル、テトラヒドロフラ
ン、ジオキサン、ジイソプロピルエーテルなどのエーテ
ル類;ジメチルスルホキシドなどのスルホキシド類;ジ
メチルホルムアミド、ジメチルアセトアミド、ヘキサメ
チル燐酸トリアミド、N−メチルピロリドンなどのアミ
ド類;テトラメチル尿素などが挙げられる。これらの溶
媒は、単独でもあるいはこれらの混合物の状態のいづれ
でも使用することができる。Any reaction solvent may be used as long as it does not inhibit the reaction, and the reaction raw materials may not be completely dissolved. For example, aromatic hydrocarbons such as benzene, mesitylene, toluol, and xylol; heterocyclic compounds such as pyridine; ethers such as diethyl ether, tetrahydrofuran, dioxane, diisopropyl ether; sulfoxides such as dimethyl sulfoxide; dimethylformamide, dimethylacetamide , Hexamethylphosphoric acid triamide, N-methylpyrrolidone and other amides; tetramethylurea and the like. These solvents can be used alone or in the form of a mixture thereof.
【0031】本発明の反応において使用する溶媒の量
は、厳密に臨界的なものではなく、例えば、原料物質の
全重量を基準にして、約5重量%またはそれ以下ないし
約30重量%またはそれ以上に亘ることができる。The amount of solvent used in the reaction of the present invention is not strictly critical and is, for example, from about 5% by weight or less to about 30% by weight or more, based on the total weight of the starting materials. The above can be extended.
【0032】本発明の方法によって生成した目的物生成
物は、結晶化法によって単離することができる。例え
ば、粗製反応生成物を、大気圧または減圧の下で濃縮
し、次いでこれにメタノール、エタノール、イソプロパ
ノール、アミルアルコール、ブタノール、t−ブタノー
ルなどの低級アルコールあるいはアセトンを加えて溶解
させる。こうして得られた溶液に、無機酸または有機酸
を添加して、目的生成物を結晶として析出させる。これ
らの結晶化用の酸は特に限定されるものではないが、例
えば塩酸、臭化水素酸、沃化水素酸などのハロゲン化水
素酸が特に望ましい。The target product produced by the method of the present invention can be isolated by a crystallization method. For example, the crude reaction product is concentrated under atmospheric pressure or reduced pressure, and then a lower alcohol such as methanol, ethanol, isopropanol, amyl alcohol, butanol, t-butanol, or acetone is added and dissolved. An inorganic acid or an organic acid is added to the solution thus obtained to precipitate the desired product as crystals. These crystallization acids are not particularly limited, but hydrohalic acids such as hydrochloric acid, hydrobromic acid and hydroiodic acid are particularly desirable.
【0033】[0033]
【0034】次に実施例を挙げて、本発明をさらに詳し
く説明する。ただし、本発明はこれらの実施例のみに限
定されるものではない。Next, the present invention will be described in more detail with reference to examples. However, the present invention is not limited to these examples.
【0035】実施例1 4−(p−クロロベンジル)−2−〔N−メチル−パー
ヒドロアゼピニル−(4)〕−1−(2H)−フタラジ
ノン塩酸塩Example 1 4- (p-chlorobenzyl) -2- [N-methyl-perhydroazepinyl- (4)]-1- (2H) -phthalazinone hydrochloride
【0036】[0036]
【化12】 [Chemical 12]
【0037】トリフェニルホスフィン236.1gをテ
トラヒドロフラン1リットルに溶解後、−30℃に冷却
し、これにジエチルアゾジカルボキシレート156.8
gを滴下した。さらに4−(p−クロロベンジル)−1
−(2H)−フタラジノン81.2gを加えた後、N−
メチル−4−ホモピペリジノール38.9gをテトラヒ
ドロフラン100mlに溶解した溶液を滴下した。これ
を−30℃に保ち16時間、ついで20℃で5時間攪拌
した後、反応液を減圧下50℃で濃縮した。残渣をイソ
プロピルアルコール1リットルに溶解後、濃塩酸を加え
た。析出した結晶を吸引濾過し、イソプロピルアルコー
ルで洗浄した。これを乾燥して目的物を白色の粉末性結
晶として106.7g(収率85%)得た。After dissolving 236.1 g of triphenylphosphine in 1 liter of tetrahydrofuran, it was cooled to -30 ° C., and diethyl azodicarboxylate 156.8 was added thereto.
g was added dropwise. Furthermore, 4- (p-chlorobenzyl) -1
After adding 81.2 g of-(2H) -phthalazinone, N-
A solution prepared by dissolving 38.9 g of methyl-4-homopiperidinol in 100 ml of tetrahydrofuran was added dropwise. The mixture was stirred at -30 ° C for 16 hours and then at 20 ° C for 5 hours, and then the reaction solution was concentrated under reduced pressure at 50 ° C. The residue was dissolved in 1 liter of isopropyl alcohol, and concentrated hydrochloric acid was added. The precipitated crystals were suction filtered and washed with isopropyl alcohol. This was dried to obtain 106.7 g (yield 85%) of the desired product as white powdery crystals.
【0038】融点:225℃Melting point: 225 ° C.
【0039】質量スペクトル(m/e):381
(M+ )Mass spectrum (m / e): 381
(M + )
【0040】 元素分析値: C H N 理論値(%) 63.16 6.02 10.04 測定値(%) 63.05 6.07 10.08Elemental analysis value: C H N theoretical value (%) 63.16 6.02 10.04 measured value (%) 63.05 6.07 10.08
【0041】赤外線吸収スペクトル(cm-1,ヌジヨー
ル):3050、2930、1655、1590、14
90、690Infrared absorption spectrum (cm -1 , Nudijol): 3050, 2930, 1655, 1590, 14
90,690
【0042】1H−NMRスペクトル(δ,D2 O):
2.1〜2.4(b,6H)、2.9(s,3H)、
3.3〜3.6(b,4H)、4.6(s,2H)、
5.4(m,1H)、7.5(m,4H)、8.1
(m,3H)、8.5(m,1H) 1 H-NMR spectrum (δ, D 2 O):
2.1-2.4 (b, 6H), 2.9 (s, 3H),
3.3-3.6 (b, 4H), 4.6 (s, 2H),
5.4 (m, 1H), 7.5 (m, 4H), 8.1
(M, 3H), 8.5 (m, 1H)
【0043】実施例2 4−(p−クロロベンジル)−2−〔N−メチル−パー
ヒドロアゼピニル−(4)〕−1−(2H)−フタラジ
ノン塩酸塩Example 2 4- (p-chlorobenzyl) -2- [N-methyl-perhydroazepinyl- (4)]-1- (2H) -phthalazinone hydrochloride
【0044】[0044]
【化13】 [Chemical 13]
【0045】トリフェニルホスフィン23.6gをテト
ラヒドロフラン200mlに溶解後、−30℃に冷却
し、これにジエチルアゾジカルボキシレート15.7g
を滴下した。同温度でさらに4−(p−クロロベンジ
ル)−1−(2H)−フタラジノン8.1gを加えた
後、N−メチル−4−ホモピペリジノール3.9gをテ
トラヒドロフラン10mlに溶解した溶液を滴下した。
これを−30℃で16時間、ついで20℃で5時間攪拌
した後、濃塩酸4.8gを加えた。続いてアセトン40
0mlを加えて濾過、乾燥して目的物を白色の粉末性結
晶として10.7g(収率85%)を得た。After dissolving 23.6 g of triphenylphosphine in 200 ml of tetrahydrofuran, it was cooled to -30 ° C., and 15.7 g of diethylazodicarboxylate was added thereto.
Was dripped. After further adding 8.1 g of 4- (p-chlorobenzyl) -1- (2H) -phthalazinone at the same temperature, a solution of 3.9 g of N-methyl-4-homopiperidinol dissolved in 10 ml of tetrahydrofuran was added dropwise. did.
This was stirred at -30 ° C for 16 hours and then at 20 ° C for 5 hours, and then concentrated hydrochloric acid (4.8 g) was added. Then acetone 40
0 ml was added, filtered and dried to obtain 10.7 g (yield 85%) of the desired product as white powdery crystals.
【0046】物性値は実施例1のそれと一致した。The physical properties were in agreement with those of Example 1.
【0047】実施例3 4−(p−クロロベンジル)−2−〔N−メチル−パー
ヒドロアゼピニル−(4)〕−1−(2H)−フタラジ
ノン塩酸塩Example 3 4- (p-chlorobenzyl) -2- [N-methyl-perhydroazepinyl- (4)]-1- (2H) -phthalazinone hydrochloride
【0048】[0048]
【化14】 [Chemical 14]
【0049】トリフェニルホスフィン118.0gをテ
トラヒドロフラン500mlに溶解後、−30℃に冷却
し、これにジイソプロピルアゾジカルボキシレート9
1.0gを滴下した。同温度でさらに4−(p−クロロ
ベンジル)−1−(2H)−フタラジノン40.5gを
加えた後、N−メチル−4−ホモピペリジノール19.
5gをテトラヒドロフラン50mlに溶解した溶液を滴
下した。−30℃で16時間、ついで20℃で5時間攪
拌した後、濃塩酸24gを加えた。続いてアセトン2リ
ットルを加えて濾過、乾燥して白色の粉末性結晶として
目的物53.5g(収率85%)を得た。After dissolving 118.0 g of triphenylphosphine in 500 ml of tetrahydrofuran, it was cooled to -30 ° C., and diisopropylazodicarboxylate 9 was added thereto.
1.0g was dripped. After adding 40.5 g of 4- (p-chlorobenzyl) -1- (2H) -phthalazinone at the same temperature, N-methyl-4-homopiperidinol 19.
A solution prepared by dissolving 5 g in 50 ml of tetrahydrofuran was added dropwise. After stirring at −30 ° C. for 16 hours and then at 20 ° C. for 5 hours, 24 g of concentrated hydrochloric acid was added. Subsequently, 2 liters of acetone was added, filtered and dried to obtain 53.5 g (yield 85%) of the desired product as white powdery crystals.
【0050】物性値は実施例1のそれと一致した。The physical properties were in agreement with those of Example 1.
【0051】実施例4 4−(p−クロロベンジル)−2−〔N−メチル−パー
ヒドロアゼピニル−(4)〕−1−(2H)−フタラジ
ノン塩酸塩Example 4 4- (p-chlorobenzyl) -2- [N-methyl-perhydroazepinyl- (4)]-1- (2H) -phthalazinone hydrochloride
【0052】[0052]
【化15】 [Chemical 15]
【0053】トリフェニルホスフィン23.6gをテト
ラヒドロフラン200mlに溶解後、−30℃に冷却
し、これにジエチルアゾジカルボキシレート15.7g
を滴下した。同温度でさらに4−(p−クロロベンジ
ル)−1−(2H)−フタラジノン8.1gを加えた
後、N−メチル−4−ホモピペリジノール3.9gをテ
トラヒドロフラン10mlに溶解した溶液を滴下した。
これを順次−30℃で5時間、0℃で5時間、20℃で
5時間攪拌した後、濃塩酸4.8gを加えた。続いてア
セトン400mlを加えて濾過、乾燥して白色の粉末性
結晶として目的物を10.7g(収率85%)得た。After dissolving 23.6 g of triphenylphosphine in 200 ml of tetrahydrofuran, it was cooled to -30 ° C., and 15.7 g of diethylazodicarboxylate was added thereto.
Was dripped. After further adding 8.1 g of 4- (p-chlorobenzyl) -1- (2H) -phthalazinone at the same temperature, a solution of 3.9 g of N-methyl-4-homopiperidinol dissolved in 10 ml of tetrahydrofuran was added dropwise. did.
This was sequentially stirred at -30 ° C for 5 hours, 0 ° C for 5 hours, and 20 ° C for 5 hours, and then 4.8 g of concentrated hydrochloric acid was added. Subsequently, 400 ml of acetone was added, filtered, and dried to obtain 10.7 g (yield 85%) of the desired product as white powdery crystals.
【0054】物性値は実施例1のそれと一致した。The physical properties were in agreement with those of Example 1.
【化16】 [Chemical 16]
【化17】 [Chemical 17]
【化18】 [Chemical 18]
Claims (6)
またはその塩を、一般式(2) 【化2】 (式中、R1 は低級アルキル基を示す)で表わされる化
合物またはその塩と、脱水縮合剤の存在下で反応させる
ことを特徴とする、一般式(3) 【化3】 (式中、XおよびR1 は前記の定義と同じ)で表わされ
るベンジルフタラジノン誘導体およびその塩の製法。1. A compound represented by the general formula (1): The compound represented by the formula (wherein X represents a halogen atom) or a salt thereof is represented by the following general formula (2): (Wherein R 1 represents a lower alkyl group) or a salt thereof is reacted in the presence of a dehydration condensing agent, and the compound represented by the general formula (3): (Wherein X and R 1 are the same as defined above), and a method for producing a benzylphthalazinone derivative and a salt thereof.
ある請求項1のベンジルフタラジノン誘導体およびその
塩の製法。2. A process for producing a benzylphthalazinone derivative or a salt thereof according to claim 1 , wherein X is a chlorine atom and R 1 is a methyl group.
(5) 【化5】 (R3)3P (5) (式中、R3はアリール基または低級アルキル基を示
す)で表わされるホスフィン誘導体とを用いる請求項1
のベンジルフタラジノン誘導体およびその塩の製法。3. A dehydration-condensation agent represented by the general formula (4): An azodicarboxylic acid ester represented by the following formula and a phosphine derivative represented by the general formula (5): (R 3 ) 3 P (5) (wherein R 3 represents an aryl group or a lower alkyl group). Claim 1 to be used
A method for producing a benzylphthalazinone derivative and a salt thereof.
ボキシレートと、トリフェニルホスフィンとを組合わせ
たもの、あるいはジイソプロピルアゾジカルボキシレー
トとトリフェニルホスフィンとを組合わせたものを用い
る請求項3のベンジルフタラジノン誘導体およびその塩
の製法。4. The benzyl as claimed in claim 3, wherein the dehydration condensing agent is a combination of diethylazodicarboxylate and triphenylphosphine, or a combination of diisopropylazodicarboxylate and triphenylphosphine. Process for producing phthalazinone derivative and its salt.
フタラジノン誘導体の製法。5. The method for producing the benzylphthalazinone derivative according to claim 1, wherein the salt is a hydrochloride.
般式(2)で表わされる化合物と、−80℃ないし10
0℃に亘る温度で反応させる請求項1記載のベンジルフ
タラジノン誘導体およびその塩の製法。6. A compound represented by the general formula (1) is combined with a compound represented by the general formula (2) at −80 ° C. to 10 ° C.
The method for producing a benzylphthalazinone derivative or a salt thereof according to claim 1, wherein the reaction is carried out at a temperature of 0 ° C.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP33284491A JPH0739413B2 (en) | 1990-11-28 | 1991-11-22 | Method for producing benzylphthalazinone derivative |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2-322399 | 1990-11-28 | ||
| JP2322399A JPH04198180A (en) | 1990-11-28 | 1990-11-28 | Production of benzylphthalazone derivative |
| JP33284491A JPH0739413B2 (en) | 1990-11-28 | 1991-11-22 | Method for producing benzylphthalazinone derivative |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPH0692960A JPH0692960A (en) | 1994-04-05 |
| JPH0739413B2 true JPH0739413B2 (en) | 1995-05-01 |
Family
ID=26570800
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP33284491A Expired - Lifetime JPH0739413B2 (en) | 1990-11-28 | 1991-11-22 | Method for producing benzylphthalazinone derivative |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPH0739413B2 (en) |
-
1991
- 1991-11-22 JP JP33284491A patent/JPH0739413B2/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| JPH0692960A (en) | 1994-04-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US8426586B2 (en) | Process for preparing amino crotonyl compounds | |
| US20080103305A1 (en) | Process for the preparation of imatinib | |
| JP5656952B2 (en) | Piperazine derivative oxalate crystals | |
| CN111217759A (en) | A kind of compound and preparation method thereof | |
| EP2451786B1 (en) | Improved process for the preparation of ambrisentan and novel intermediates thereof | |
| NO314456B1 (en) | Methods and intermediates useful for preparing antifolates | |
| WO2012174685A1 (en) | Preparation method of 2-substituted-2h-1,2,3-triazole derivative | |
| US9663490B2 (en) | Process for making reverse transcriptase inhibitors | |
| JP2005526049A (en) | Preparation of benzisoxazole methanesulfonyl chloride and its method of amidation to form zonisamide | |
| US9695124B2 (en) | Method of producing 2-aminonicotinic acid benzyl ester derivatives | |
| JPH04198180A (en) | Production of benzylphthalazone derivative | |
| US6891041B2 (en) | Method for producing 4-(heteroaryl-methyl)-halogen-1(2H)-phthalazinones | |
| US20060142595A1 (en) | Process for preparing 5,6-dihydro-4-(S)-(ethylamino)-6-(S) methyl-4H-thieno[2,3b]thiopyran-2-sulphonamide-7,7-dioxide HCI | |
| JPH0739413B2 (en) | Method for producing benzylphthalazinone derivative | |
| JP4026233B2 (en) | Method for producing 4,5-dichloro-6- (α-fluoroalkyl) pyrimidine | |
| NO147838B (en) | INTERMEDIATE FOR USE IN PREPARATION OF THE HYPOTENSIVE AGENT 2- (4- (2-FUROYL) PIPERAZIN-1-YL) -4-AMINO-6,7-DIMETOXYKINAZOLINE | |
| WO2011021216A2 (en) | Improved process for the preparation of 4-(1,1-dimethylethyl)-n-[6-(2-hydroxyethoxy)-5-(2-methoxyphenoxy)[2,2'-bipyrimidin]-4-yl]benzenesulfonamide | |
| US20140275535A1 (en) | Acid addition salts of bosentan | |
| JP4502280B2 (en) | Method for producing sulfaminecarboxylic acid derivative | |
| US7238719B2 (en) | Process for producing 1,2,3-Triazole compounds | |
| US20110071302A1 (en) | Process for preparing intermediate compound for synthesizing an antiulcerant | |
| JP3537050B2 (en) | Method for producing 3-chloromethyl-3-cephem derivative crystal | |
| KR102004422B1 (en) | A preparation method of bosentan monohydrate, novel intermediate useful for the preparation of bosentan monohydrate, and the preparation method thereof | |
| KR20200088570A (en) | Process for Preparation of Fimasartan and Intermediate for Preparing the Same | |
| US6248888B1 (en) | Process for the preparation of terazosin hydrochloride dihydrate |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| S111 | Request for change of ownership or part of ownership |
Free format text: JAPANESE INTERMEDIATE CODE: R313111 |
|
| R350 | Written notification of registration of transfer |
Free format text: JAPANESE INTERMEDIATE CODE: R350 |
|
| FPAY | Renewal fee payment (prs date is renewal date of database) |
Year of fee payment: 13 Free format text: PAYMENT UNTIL: 20080501 |
|
| FPAY | Renewal fee payment (prs date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20090501 Year of fee payment: 14 |
|
| FPAY | Renewal fee payment (prs date is renewal date of database) |
Year of fee payment: 14 Free format text: PAYMENT UNTIL: 20090501 |
|
| FPAY | Renewal fee payment (prs date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20100501 Year of fee payment: 15 |
|
| FPAY | Renewal fee payment (prs date is renewal date of database) |
Year of fee payment: 16 Free format text: PAYMENT UNTIL: 20110501 |
|
| FPAY | Renewal fee payment (prs date is renewal date of database) |
Year of fee payment: 17 Free format text: PAYMENT UNTIL: 20120501 |
|
| EXPY | Cancellation because of completion of term | ||
| FPAY | Renewal fee payment (prs date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20120501 Year of fee payment: 17 |